Jan 14, 2025
1:5
For every 5 shares held, investors received 1. The price per share adjusted from $0.76 to $0.15.
The split itself did not change the total investment value.
Evaxion Biotech A/S (EVAX) trades on the NASDAQ Capital Market in the Biotechnology industry.
Evaxion Biotech A/S company overviewThe latest split shown was on January 14, 2025. It was a 1-for-5 reverse split, so shareholders received 1 share for every 5 they held.
This history records 2 reverse splits between January 22, 2024 and January 14, 2025.
Already premium?